标题
Derivatization with fatty acids in peptide and protein drug discovery
作者
关键词
-
出版物
NATURE REVIEWS DRUG DISCOVERY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-08-24
DOI
10.1038/s41573-022-00529-w
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Oligomerization, albumin binding and catabolism of therapeutic peptides in the subcutaneous compartment: An investigation on lipidated GLP-1 analogs
- (2022) Mariana Gallo et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates
- (2022) Kirk M. Brown et al. NATURE BIOTECHNOLOGY
- Therapeutic RNA-silencing oligonucleotides in metabolic diseases
- (2022) Algera Goga et al. NATURE REVIEWS DRUG DISCOVERY
- Lipidated PrRP31 metabolites are long acting dual GPR10 and NPFF2 receptor agonists with potent body weight lowering effect
- (2022) Flora Alexopoulou et al. Scientific Reports
- Tirzepatide Once Weekly for the Treatment of Obesity
- (2022) Ania M. Jastreboff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Opportunities and Challenges of Fatty Acid Conjugated Therapeutics
- (2021) Medha Bhat et al. CHEMISTRY AND PHYSICS OF LIPIDS
- Trends in peptide drug discovery
- (2021) Markus Muttenthaler et al. NATURE REVIEWS DRUG DISCOVERY
- Once-Weekly Semaglutide in Adults with Overweight or Obesity
- (2021) John P.H. Wilding et al. NEW ENGLAND JOURNAL OF MEDICINE
- Importance of the route of insulin delivery to its control of glucose metabolism
- (2021) Dale S. Edgerton et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Effect of Oral Semaglutide on the Pharmacokinetics of Levonorgestrel and Ethinylestradiol in Healthy Postmenopausal Women and Furosemide and Rosuvastatin in Healthy Subjects
- (2021) Andreas B. Jordy et al. CLINICAL PHARMACOKINETICS
- Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials
- (2021) Rune V. Overgaard et al. CLINICAL PHARMACOKINETICS
- Zilucoplan: An Investigational Complement C5 Inhibitor for the Treatment of Acetylcholine Receptor Autoantibody–Positive Generalized Myasthenia Gravis
- (2021) James F. Howard et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Molecular Engineering of Insulin Icodec, the First Acylated Insulin Analog for Once-Weekly Administration in Humans
- (2021) Thomas B. Kjeldsen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial
- (2021) Lone B Enebo et al. LANCET
- The Uniqueness of Albumin as a Carrier in Nanodrug Delivery
- (2021) Alessandra Spada et al. MOLECULAR PHARMACEUTICS
- Development of Cagrilintide, a Long-Acting Amylin Analogue
- (2021) Thomas Kruse et al. JOURNAL OF MEDICINAL CHEMISTRY
- Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
- (2021) Julio Rosenstock et al. LANCET
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
- (2021) Juan P. Frías et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rational Development of Stable PYY3–36 Peptide Y2 Receptor Agonists
- (2021) Christian Poulsen et al. PHARMACEUTICAL RESEARCH
- Commemorating insulin's centennial: engineering insulin pharmacology towards physiology
- (2021) Peter Kurtzhals et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Efficacy of Semaglutide in a Subcutaneous and an Oral Formulation
- (2021) Juris J. Meier Frontiers in Endocrinology
- Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing
- (2021) Erica Nishimura et al. BMJ Open Diabetes Research & Care
- Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1/GIP/GCG receptor triagonist
- (2021) Martin Bossart et al. Cell Metabolism
- Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: A systematic literature review
- (2021) Marc Evans et al. DIABETES OBESITY & METABOLISM
- Structure identification of circulating metabolites from somapacitan, a long-acting growth hormone derivative, and pharmacokinetics after single and multiple subcutaneous dosing in rats
- (2021) Hans Helleberg et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
- (2021) David C W Lau et al. LANCET
- Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
- (2021) Stefano Del Prato et al. LANCET
- Assay format diversity in pre-clinical immunogenicity risk assessment: Toward a possible harmonization of antigenicity assays
- (2021) Axel Ducret et al. mAbs
- Anti-obesity drug discovery: advances and challenges
- (2021) Timo D. Müller et al. NATURE REVIEWS DRUG DISCOVERY
- The effect of fatty diacid acylation of human PYY3-36 on Y2 receptor potency and half-life in minipigs
- (2021) Søren Østergaard et al. Scientific Reports
- Fatty acylation enhances the cellular internalization and cytosolic distribution of a cystine-knot peptide
- (2021) Xinxin Gao et al. iScience
- Once-weekly somapacitan is effective and well tolerated in adults with GH deficiency: a randomized phase 3 trial
- (2020) Gudmundur Johannsson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Identification of Binding Sites on Human Serum Albumin for Somapacitan, a Long-Acting Growth Hormone Derivative
- (2020) Eva Johansson et al. BIOCHEMISTRY
- Albumin-based drug designs for pharmacokinetic modulation
- (2020) Diego Pilati et al. Expert Opinion on Drug Metabolism & Toxicology
- Influence of Production Process and Scale on Quality of Polypeptide Drugs: a Case Study on GLP-1 Analogs
- (2020) Arne Staby et al. PHARMACEUTICAL RESEARCH
- Molecular engineering of safe and efficacious oral basal insulin
- (2020) Frantisek Hubálek et al. Nature Communications
- An intact C-terminal end of albumin is required for its long half-life in humans
- (2020) Jeannette Nilsen et al. Communications Biology
- Beneficial actions of a long‐acting apelin analogue in diabetes are related to positive effects on islet cell turnover and transdifferentiation
- (2020) Neil Tanday et al. DIABETES OBESITY & METABOLISM
- Engineering of a Potent, Long-Acting NPY2R Agonist for Combination with a GLP-1R Agonist as a Multi-Hormonal Treatment for Obesity
- (2020) Sam Lear et al. JOURNAL OF MEDICINAL CHEMISTRY
- Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment
- (2020) Julio Rosenstock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Engineering of Orally Available, Ultralong-Acting Insulin Analogues: Discovery of OI338 and OI320
- (2020) Thomas B. Kjeldsen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Docosanoic acid conjugation to siRNA enables functional and safe delivery to skeletal and cardiac muscles
- (2020) Annabelle Biscans et al. MOLECULAR THERAPY
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structure-Activity Relationships and Characterization of Highly Selective, Long Acting, Peptide-based Cholecystokinin 1 Receptor (CCK-1R) Agonists
- (2019) Ulrich Sensfuss et al. JOURNAL OF MEDICINAL CHEMISTRY
- Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial
- (2019) Inge B Halberg et al. Lancet Diabetes & Endocrinology
- The current state and future directions of RNAi-based therapeutics
- (2019) Ryan L. Setten et al. NATURE REVIEWS DRUG DISCOVERY
- Development of long-acting recombinant glycoprotein hormones by increasing the carbohydrate content
- (2019) Fuad Fares et al. DRUG DISCOVERY TODAY
- Apelin peptides linked to anti‐serum albumin domain antibodies retain affinity in vitro and are efficacious receptor agonists in vivo
- (2019) Cai Read et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- The Effect of Food Intake on the Pharmacokinetics of Oral Basal Insulin: A Randomised Crossover Trial in Healthy Male Subjects
- (2019) Inge B. Halberg et al. CLINICAL PHARMACOKINETICS
- Peripherally delivered hepatopreferential insulin analog insulin‐406 mimics the hypoglycaemia‐sparing effect of portal vein human insulin infusion in dogs
- (2019) Justin M. Gregory et al. DIABETES OBESITY & METABOLISM
- Long-acting CCK analogue NN9056 lowers food intake and body weight in obese Göttingen Minipigs
- (2019) Berit Ø. Christoffersen et al. INTERNATIONAL JOURNAL OF OBESITY
- Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial
- (2019) Richard Pratley et al. LANCET
- Half-Life Extending Modifications of Peptide YY3–36 Direct Receptor-Mediated Internalization
- (2019) Esben M. Bech et al. MOLECULAR PHARMACEUTICS
- Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2019) Mansoor Husain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fatty acid conjugation enhances potency of antisense oligonucleotides in muscle
- (2019) Thazha P Prakash et al. NUCLEIC ACIDS RESEARCH
- Design of a Long-Acting and Selective MEG-Fatty Acid Stapled Prolactin-Releasing Peptide Analog
- (2019) Elsa Pflimlin et al. ACS Medicinal Chemistry Letters
- Chemical Methods for Selective Labeling of Proteins
- (2019) Dattatraya G. Rawale et al. EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
- Disulfide‐Based Self‐Immolative Linkers and Functional Bioconjugates for Biological Applications
- (2019) Zhengyu Deng et al. MACROMOLECULAR RAPID COMMUNICATIONS
- Solid-Phase Thiol-ene Lipidation of Peptides for the Synthesis of a Potent CGRP Receptor Antagonist
- (2018) Margaret Anne Brimble et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The Effect of Lipidation on the Self-Assembly of the Gut-Derived Peptide Hormone PYY3–36
- (2018) Jessica A. Hutchinson et al. BIOCONJUGATE CHEMISTRY
- Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects with Renal Impairment
- (2018) Charlotte Granhall et al. CLINICAL PHARMACOKINETICS
- MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study
- (2018) Philip Ambery et al. LANCET
- The effect of acylation with fatty acids and other modifications on HLA class II:peptide binding and T cell stimulation for three model peptides
- (2018) Heidi S. Schultz et al. PLoS One
- Evaluating and Mitigating the Immunogenicity of Therapeutic Proteins
- (2018) Zuben E. Sauna et al. TRENDS IN BIOTECHNOLOGY
- Improving siRNA Delivery In Vivo Through Lipid Conjugation
- (2018) Maire F. Osborn et al. Nucleic Acid Therapeutics
- Molecular Size Modulates Pharmacokinetics, Biodistribution, and Renal Deposition of the Drug Delivery Biopolymer Elastin-like Polypeptide
- (2018) Marija Kuna et al. Scientific Reports
- Factors Affecting the Absorption of Subcutaneously Administered Insulin: Effect on Variability
- (2018) A. K. J. Gradel et al. Journal of Diabetes Research
- Harnessing albumin as a carrier for cancer therapies
- (2018) Ella N. Hoogenboezem et al. ADVANCED DRUG DELIVERY REVIEWS
- Long-Acting Human Growth Hormone Analogue by Noncovalent Albumin Binding
- (2018) Henrik S. Ramírez-Andersen et al. BIOCONJUGATE CHEMISTRY
- A novel dual glucagon-like peptide and glucagon receptor agonist SAR425899: Results of randomized, placebo-controlled first-in-human and first-in-patient trials
- (2018) Joachim Tillner et al. DIABETES OBESITY & METABOLISM
- Selective N-terminal acylation of peptides and proteins with a Gly-His tag sequence
- (2018) Manuel C. Martos-Maldonado et al. Nature Communications
- Design and Synthesis of Potent, Long-Acting Lipidated Relaxin-2 Analogs
- (2018) Avinash Muppidi et al. BIOCONJUGATE CHEMISTRY
- Design of novel lipidated peptidomimetic conjugates for targeting EGFR heterodimerization in HER2 + cancer
- (2018) Himgauri Naik et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Safety and Pharmacokinetics of Single and Multiple Ascending Doses of the Novel Oral Human GLP-1 Analogue, Oral Semaglutide, in Healthy Subjects and Subjects with Type 2 Diabetes
- (2018) Charlotte Granhall et al. CLINICAL PHARMACOKINETICS
- Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist
- (2018) Stephen T. Buckley et al. Science Translational Medicine
- LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept
- (2018) Tamer Coskun et al. Molecular Metabolism
- Absorption, metabolism and excretion of the GLP-1 analogue semaglutide in humans and nonclinical species
- (2017) Lene Jensen et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes
- (2017) Melanie Davies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Peptide Half-Life Extension: Divalent, Small-Molecule Albumin Interactions Direct the Systemic Properties of Glucagon-Like Peptide 1 (GLP-1) Analogues
- (2017) Esben M. Bech et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Current State of Peptide Drug Discovery: Back to the Future?
- (2017) Antoine Henninot et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lipid–Drug Conjugate for Enhancing Drug Delivery
- (2017) Danielle Irby et al. MOLECULAR PHARMACEUTICS
- Targeting the N terminus for site-selective protein modification
- (2017) Christian B Rosen et al. Nature Chemical Biology
- Half-life extension using serum albumin-binding DARPin® domains
- (2017) Daniel Steiner et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Post hoc assessment of the immunogenicity of bioengineered factor VIIa demonstrates the use of preclinical tools
- (2017) Kasper Lamberth et al. Science Translational Medicine
- Late-stage lipidation of fully elaborated tryptophan-containing peptides for improved pharmacokinetics
- (2017) Chunhui Huang et al. TETRAHEDRON LETTERS
- Acylated heptapeptide binds albumin with high affinity and application as tag furnishes long-acting peptides
- (2017) Alessandro Zorzi et al. Nature Communications
- Factors affecting the physical stability (aggregation) of peptide therapeutics
- (2017) Karolina L. Zapadka et al. Interface Focus
- Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
- (2017) Christopher Sorli et al. Lancet Diabetes & Endocrinology
- Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
- (2017) Vanita R Aroda et al. Lancet Diabetes & Endocrinology
- The rationale and design of TransCon Growth Hormone for the treatment of growth hormone deficiency
- (2017) Kennett Sprogøe et al. Endocrine Connections
- Development of potent and long-acting HIV-1 fusion inhibitors
- (2016) Huihui Chong et al. AIDS
- Synthesis of Lipidated Proteins
- (2016) Tom Mejuch et al. BIOCONJUGATE CHEMISTRY
- Phenylbutazone, a New Long-Acting Agent that can Improve the Peptide Pharmacokinetic Based on Serum Albumin as a Drug Carrier
- (2016) Jie Zhou et al. Chemical Biology & Drug Design
- Development of Potent and Metabolically Stable APJ Ligands with High Therapeutic Potential
- (2016) Cathleen Juhl et al. ChemMedChem
- Insulin degludec does not increase antibody formation versus insulin glargine: an evaluation of phase IIIa trials
- (2016) J. Vora et al. DIABETES OBESITY & METABOLISM
- Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primates
- (2016) S. J. Henderson et al. DIABETES OBESITY & METABOLISM
- Half-life extended biotherapeutics
- (2016) Roland E. Kontermann EXPERT OPINION ON BIOLOGICAL THERAPY
- The molecular basis for the prolonged blood circulation of lipidated incretin peptides: Peptide oligomerization or binding to serum albumin?
- (2016) Ying Wang et al. JOURNAL OF CONTROLLED RELEASE
- Extension of in vivo half-life of biologically active molecules by XTEN protein polymers
- (2016) Vladimir N. Podust et al. JOURNAL OF CONTROLLED RELEASE
- PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs
- (2016) Peter L. Turecek et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Neoglycolipids for Prolonging the Effects of Peptides: Self-Assembling Glucagon-like Peptide 1 Analogues with Albumin Binding Properties and Potent in Vivo Efficacy
- (2016) Søren B. van Witteloostuijn et al. MOLECULAR PHARMACEUTICS
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Engineering a long-acting, potent GLP-1 analog for microstructure-based transdermal delivery
- (2016) Peng-Yu Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Acyl lipidation of a peptide: effects on activity and epidermal permeability in vitro
- (2016) Rima Caccetta et al. Drug Design Development and Therapy
- Comparison of the physiological relevance of systemic vs. portal insulin delivery to evaluate whole body glucose flux during an insulin clamp
- (2015) Tiffany D. Farmer et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Self-Immolative Spacers: Kinetic Aspects, Structure-Property Relationships, and Applications
- (2015) Ahmed Alouane et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters
- (2015) William R. Strohl BIODRUGS
- Peptide stapling techniques based on different macrocyclisation chemistries
- (2015) Yu Heng Lau et al. CHEMICAL SOCIETY REVIEWS
- Synthetic protein lipidation
- (2015) Rami N Hannoush CURRENT OPINION IN CHEMICAL BIOLOGY
- Acylation of salmon calcitonin modulates in vitro intestinal peptide flux through membrane permeability enhancement
- (2015) Sofie Trier et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Novel lipidized analogs of prolactin-releasing peptide have prolonged half-lives and exert anti-obesity effects after peripheral administration
- (2015) L Maletínská et al. INTERNATIONAL JOURNAL OF OBESITY
- Design, Synthesis, and Characterization of Fatty Acid Derivatives of a Dimeric Peptide-Based Postsynaptic Density-95 (PSD-95) Inhibitor
- (2015) Klaus B. Nissen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
- (2015) Jesper Lau et al. JOURNAL OF MEDICINAL CHEMISTRY
- Transformation of Oligomers of Lipidated Peptide Induced by Change in pH
- (2015) Ying Wang et al. MOLECULAR PHARMACEUTICS
- Site-selective protein-modification chemistry for basic biology and drug development
- (2015) Nikolaus Krall et al. Nature Chemistry
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fc fusion as a platform technology: potential for modulating immunogenicity
- (2015) Ditza Levin et al. TRENDS IN BIOTECHNOLOGY
- Position and Length of Fatty Acids Strongly Affect Receptor Selectivity Pattern of Human Pancreatic Polypeptide Analogues
- (2014) Veronika Mäde et al. ChemMedChem
- A Review of the Pharmacological Properties of Insulin Degludec and Their Clinical Relevance
- (2014) Hanne Haahr et al. CLINICAL PHARMACOKINETICS
- GSK2374697, a Novel Albumin-Binding Domain Antibody (AlbudAb), Extends Systemic Exposure of Exendin-4: First Study in Humans—PK/PD and Safety
- (2014) R L O’Connor-Semmes et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Extending Serum Half-life of Albumin by Engineering Neonatal Fc Receptor (FcRn) Binding
- (2014) Jan Terje Andersen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Reversible Albumin-Binding Growth Hormone Derivative is Well Tolerated and Possesses a Potential Once-Weekly Treatment Profile
- (2014) Michael Højby Rasmussen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Synthesis and evaluation of novel lipidated neuromedin U analogs with increased stability and effects on food intake
- (2014) Louise S. Dalbøge et al. JOURNAL OF PEPTIDE SCIENCE
- A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents
- (2014) Brian Finan et al. NATURE MEDICINE
- The immune epitope database (IEDB) 3.0
- (2014) Randi Vita et al. NUCLEIC ACIDS RESEARCH
- Acylation of Glucagon-Like Peptide-2: Interaction with Lipid Membranes and In Vitro Intestinal Permeability
- (2014) Sofie Trier et al. PLoS One
- Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes
- (2014) R. Mazor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
- (2013) Nicolas Bertrand et al. ADVANCED DRUG DELIVERY REVIEWS
- Albumin as a versatile platform for drug half-life extension
- (2013) Darrell Sleep et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Preparation and Characterization of Albumin Conjugates of a Truncated Peptide YY Analogue for Half-Life Extension
- (2013) George K. Ehrlich et al. BIOCONJUGATE CHEMISTRY
- The insulin receptor changes conformation in unforeseen ways on ligand binding: Sharpening the picture of insulin receptor activation
- (2013) Colin W. Ward et al. BIOESSAYS
- Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the rat
- (2013) Weike Bao et al. Cardiovascular Diabetology
- Insulin Degludec: Pharmacokinetics in Patients with Renal Impairment
- (2013) István Kiss et al. CLINICAL PHARMACOKINETICS
- Investigation of safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of a long-acting α-MSH analog in healthy overweight and obese subjects
- (2013) Jane E. Royalty et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Site-specific fatty acid-conjugation to prolong protein half-life in vivo
- (2013) Sung In Lim et al. JOURNAL OF CONTROLLED RELEASE
- How insulin engages its primary binding site on the insulin receptor
- (2013) John G. Menting et al. NATURE
- PASylation: a biological alternative to PEGylation for extending the plasma half-life of pharmaceutically active proteins
- (2013) M. Schlapschy et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Extension of in vivo half-life of biologically active peptides via chemical conjugation to XTEN protein polymer
- (2013) V. N. Podust et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Peptide lipidation stabilizes structure to enhance biological function
- (2013) Brian P. Ward et al. Molecular Metabolism
- Mechanistic Determinants of Biotherapeutics Absorption Following SC Administration
- (2012) Wolfgang F. Richter et al. AAPS Journal
- Ligand-Controlled Assembly of Hexamers, Dihexamers, and Linear Multihexamer Structures by the Engineered Acylated Insulin Degludec
- (2012) Dorte B. Steensgaard et al. BIOCHEMISTRY
- Preparation and evaluation of palmitic acid-conjugated exendin-4 with delayed absorption and prolonged circulation for longer hypoglycemia
- (2012) Juho Lee et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Identification and in Vivo and in Vitro Characterization of Long Acting and Melanocortin 4 Receptor (MC4-R) Selective α-Melanocyte-Stimulating Hormone (α-MSH) Analogues
- (2012) Kilian Conde-Frieboes et al. JOURNAL OF MEDICINAL CHEMISTRY
- Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial
- (2012) Alan J Garber et al. LANCET
- Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial
- (2012) Simon Heller et al. LANCET
- RNA therapeutics: beyond RNA interference and antisense oligonucleotides
- (2012) Ryszard Kole et al. NATURE REVIEWS DRUG DISCOVERY
- Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-long-Acting Basal Insulin
- (2012) Ib Jonassen et al. PHARMACEUTICAL RESEARCH
- Predictable and tunable half-life extension of therapeutic agents by controlled chemical release from macromolecular conjugates
- (2012) D. V. Santi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PEGylation of Proteins and Liposomes: a Powerful and Flexible Strategy to Improve the Drug Delivery
- (2011) Paola Milla et al. CURRENT DRUG METABOLISM
- Pramlintide and the treatment of diabetes: a review of the data since its introduction
- (2011) Lisa M Younk et al. EXPERT OPINION ON PHARMACOTHERAPY
- Liraglutide Treatment Is Associated with a Low Frequency and Magnitude of Antibody Formation with No Apparent Impact on Glycemic Response or Increased Frequency of Adverse Events: Results from the Liraglutide Effect and Action in Diabetes (LEAD) Trials
- (2011) John B. Buse et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Long-Acting Lipidated Analogue of Human Pancreatic Polypeptide Is Slowly Released into Circulation
- (2011) Kathrin Bellmann-Sickert et al. JOURNAL OF MEDICINAL CHEMISTRY
- Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift
- (2011) J. R. Cantor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glycosylation of Therapeutic Proteins
- (2010) Ricardo J. Solá et al. BIODRUGS
- PEGylation of therapeutic proteins
- (2010) Simona JevsÌevar et al. Biotechnology Journal
- Patient perspectives on once-weekly medications for diabetes
- (2010) W. H. Polonsky et al. DIABETES OBESITY & METABOLISM
- Metabolism and Excretion of the Once-Daily Human Glucagon-Like Peptide-1 Analog Liraglutide in Healthy Male Subjects and Its In Vitro Degradation by Dipeptidyl Peptidase IV and Neutral Endopeptidase
- (2010) M. Malm-Erjefalt et al. DRUG METABOLISM AND DISPOSITION
- Effects of albumin-conjugated PYY on food intake: the respective roles of the circumventricular organs and vagus nerve
- (2010) Elena-Dana Baraboi et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Population Pharmacokinetic Model of Human Insulin Following Different Routes of Administration
- (2010) Elizabeth Potocka et al. JOURNAL OF CLINICAL PHARMACOLOGY
- The fatty acid conjugated exendin-4 analogs for type 2 antidiabetic therapeutics
- (2010) Su Young Chae et al. JOURNAL OF CONTROLLED RELEASE
- Delivering nanomedicine to solid tumors
- (2010) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
- Anti-serum albumin domain antibodies in the development of highly potent, efficacious and long-acting interferon
- (2010) A. Walker et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
- (2009) John B Buse et al. LANCET
- A Portable Albumin Binder from a DNA-Encoded Chemical Library
- (2008) Christoph E. Dumelin et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal–bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial
- (2008) P. C. Bartley et al. DIABETIC MEDICINE
- Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
- (2008) Felix Kratz JOURNAL OF CONTROLLED RELEASE
- Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial
- (2008) Alan Garber et al. LANCET
- Anti-serum albumin domain antibodies for extending the half-lives of short lived drugs
- (2008) L. J. Holt et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Engineering of a femtomolar affinity binding protein to human serum albumin
- (2008) A. Jonsson et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Quantitative Predictions of Peptide Binding to Any HLA-DR Molecule of Known Sequence: NetMHCIIpan
- (2008) Morten Nielsen et al. PLoS Computational Biology
- Mutational analysis of the interaction between albumin-binding domain from streptococcal protein G and human serum albumin
- (2002) Martin Linhult et al. PROTEIN SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now